Fresenius trims Fresenius Medical Care stake to 25% in €300m share sale
The German health group sold 7.8 million shares of its dialysis subsidiary to institutional investors, using the proceeds to cut debt and fund its Kabi and Helios growth platforms.
24 August 2026
